KIT as a therapeutic target in metastatic melanoma.
Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman RA, Teitcher J, Panageas KS, Busam KJ, Chmielowski B, Lutzky J, Pavlick AC, Fusco A, Cane L, Takebe N, Vemula S, Bouvier N, Bastian BC, Schwartz GK.
Carvajal RD, et al.
JAMA. 2011 Jun 8;305(22):2327-34. doi: 10.1001/jama.2011.746.
JAMA. 2011.
PMID: 21642685
Free PMC article.
Clinical Trial.